Skip to main content
Access Resources

MJFF Publications

421 - 430 of 7370 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • OPEN
    Title: Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson’s disease patients
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-023-00348-y
    Citation Count: 3
  • OPEN
    Title: A Predictive Visual Analytics System for Studying Neurodegenerative Disease Based on DTI Fiber Tracts
    Journal Name: IEEE Transactions on Visualization and Computer Graphics
    Publisher: Institute of Electrical and Electronics Engineers (IEEE)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1109/tvcg.2021.3137174
    Best OA location URL: http://arxiv.org/pdf/2010.07047
    Citation Count: 1
  • RESTRICTED
    Title: Cumulative Effect of Head Injuries on Nonmotor Outcomes in Parkinson’s Disease
    Journal Name: The Journal of Neuropsychiatry and Clinical Neurosciences
    Publisher: American Psychiatric Association Publishing
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1176/appi.neuropsych.21100257
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Distribution of cholinergic nerve terminals in the aged human brain measured with [18F]FEOBV PET and its correlation with histological data
    Journal Name: NeuroImage
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.neuroimage.2023.119908
    Citation Count: 2
  • OPEN
    Title: High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy
    Journal Name: SLAS Discovery
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.slasd.2022.12.004
    Citation Count: 3
  • RESTRICTED
    Title: Imaging-based DBS programming help: Does it help?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105362
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Motor response with apomorphine sublingual film and levodopa in patients with OFF episodes
    Journal Name: Neurodegenerative Disease Management
    Publisher: Future Medicine Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/nmt-2022-0038
    Citation Count: 1
  • OPEN
    Title: Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force
    Journal Name: Value in Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jval.2022.12.006
    Citation Count: 6
  • OPEN
    Title: Olfactory Impairment Is the Main Predictor of Higher Scores at REM Sleep Behavior Disorder (RBD) Screening Questionnaire in Parkinson’s Disease Patients
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13040599
    Citation Count: 3
  • RESTRICTED
    Title: Workflows Community Summit 2022: A Roadmap Revolution
    Journal Name:
    Publisher:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.5281/zenodo.7750670
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.